Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer

NCT00295802 is registered in ClinicalTrials.gov with EDAP TMS S.A. as lead sponsor.

NCT NCT00295802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00295802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer
Lead sponsor
EDAP TMS S.A.
Phase
Phase 2/3
Overall status
Unknown status
Start date
April 30, 2006
Completion date
September 30, 2014
Enrollment
141 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer